Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear accelerator | Zendy

Andrew R. Barsky | Zendy; Michele M. Kim | Zendy; Russell Maxwell | Zendy; Amberly Mendes | Zendy; Christopher M. Wright | Zendy; Emily J. Anstadt | Zendy; Sally McNulty | Zendy; Dong Lei | Zendy; James M. Metz | Zendy; Steven J. Feigenberg | Zendy; Taoran Li | Zendy; Keith A. Cengel | Zendy

Open Access

Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear accelerator

Author(s) -

Andrew R. Barsky,

Michele M. Kim,

Russell Maxwell,

Amberly Mendes,

Christopher M. Wright,

Emily J. Anstadt,

Sally McNulty,

Dong Lei,

James M. Metz,

Steven J. Feigenberg,

Taoran Li,

Keith A. Cengel

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-385

Subject(s) - medicine , mesothelioma , radiation therapy , palliative care , oncology , radiology , pathology , nursing

Radiation therapy (RT) can provide effective symptomatic palliation in patients with malignant pleural mesothelioma (MPM). Advances in RT technology, including intensity-modulated RT (IMRT) and volumetric-modulated arc therapy (VMAT), have improved treatment conformality, potentially improving the therapeutic ratio of RT. A novel 6-MV flattening-filter-free O-ring linear accelerator, HalcyonTM (Varian Medical Systems, Palo Alto, CA, USA), was built to provide such advanced therapies, while possibly reducing treatment time. Here, we report the initial clinical experience using HalcyonTM to deliver palliative RT for patients with MPM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research